Form 4: Envoy Medical Director Receives Shares in Pro-Rata Distribution

Susan Kantor, a director at Envoy Medical, received 34,705 shares of Class A Common Stock through a pro-rata distribution.

Summary

• Susan Kantor, a director of Envoy Medical, received 34,705 shares of Class A Common Stock on December 23, 2024.
• The shares were distributed in-kind by Anzu SPAC GP I LLC to its members.
• The distribution was pro-rata and the shares were received for no consideration.
• Following the transaction, Ms. Kantor directly owns 77,887 shares of Envoy Medical Class A Common Stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, with no negative implications. The increase in director's holdings could be seen as a positive sign.

Positives

• The transaction increases the director's stake in the company, potentially aligning her interests with shareholders.

Industry Context

This is a standard SEC Form 4 filing, which is common when company insiders acquire or dispose of shares. It provides transparency into the ownership changes of company directors.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The pro-rata distribution of shares is a common method of distributing assets from a parent company to its members.

Stakeholder Impact

• The transaction increases the director's stake in the company, potentially aligning her interests with shareholders.

Key Dates

Keywords

Form 4, Beneficial Ownership, Director, Envoy Medical, Class A Common Stock, Pro-rata Distribution, Anzu SPAC GP I LLC, Share Acquisition